SJ Medical
SJ Medical
Advanced Drug-Eluting Stents and Critical Care Catheter Systems Certified for High-Altitude Clinical Demands
Kathmandu, as the capital and medical nerve center of Nepal, is currently undergoing a structural transformation in its healthcare infrastructure. With the rising prevalence of Cardiovascular Diseases (CVD), driven by urban epidemiological shifts, dietary changes, and high metabolic risk factors among the Himalayan population, the demand for Percutaneous Coronary Intervention (PCI) devices has surged exponentially. Leading tertiary centers such as the Shahid Gangalal National Heart Center (SGNHC), Norvic International Hospital, Nepal Mediciti Hospital, and Upendra Devkota Memorial National Institute of Neurological and Allied Sciences process thousands of diagnostic angiograms and therapeutic angioplasties annually.
Historically, medical institutions in Kathmandu relied heavily on European and North American vascular device imports. However, supply chain vulnerabilities, high procurement overheads, and lengthy import clearing windows through Tribhuvan International Airport (KTM) have created urgent hospital demand for high-performance, cost-effective alternative manufacturers. Drug-Eluting Stents (DES) featuring advanced antiproliferative agents like Sirolimus and Everolimus, combined with ultra-thin Cobalt-Chromium (CoCr) strut architectures, represent the gold standard required by Nepalese interventional cardiologists to minimize late lumen loss and in-stent restenosis (ISR).
Why Interventional Cardiology Procurement Directors in Kathmandu Trust Our Manufacturing Ecosystem
Our state-of-the-art Swiss laser cutting technology delivers ultra-thin (60-80 μm) cobalt-chromium struts, ensuring high radial strength, optimal side-branch access, and maximum deliverability through tortuous anatomy.
Utilizing micro-mist coating automation, our Sirolimus-eluting platforms feature programmable release profiles (80% eluting within 30 days), preventing neointimal hyperplasia while accelerating endothelial healing.
Streamlined logistics with direct air cargo channels from Hangzhou to Kathmandu (KTM) ensures temperature-controlled, expedited door-to-door transit within 48 to 72 hours for urgent catheter lab restocking.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide, including specialized medical tenders in Kathmandu, Nepal.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes such as drug coating spray and stent crimping.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
SJ Medical strictly adheres to international quality standards and regulatory requirements. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with Free Sale Certificates (FSC), demonstrating its strong commitment to product quality and compliance for tender requirements in Nepal.
Equipped with advanced production and inspection systems—including precision balloon forming equipment, laser welding and marking technologies, and comprehensive laboratory testing facilities—we guarantee full-process quality control from raw materials to final sterilized products.
Pioneering Technological Shifts in Interventional Vascular Therapy
Traditional permanent polymers may induce long-term chronic vascular inflammation and late stent thrombosis. Modern trends favor polymer-free DES platforms or fully biodegradable PLA/PLGA polymers that completely degrade into CO2 and H2O within 6 to 9 months, leaving a bare metal scaffold after drug elution.
Clinical data confirms that reducing strut thickness from 120 μm to sub-80 μm dramatically lowers vessel wall trauma, accelerates re-endothelialization, and reduces the required duration of Dual Antiplatelet Therapy (DAPT)—a crucial benefit for patients in remote Nepalese regions with limited follow-up access.
As the pinnacle of vascular innovation, temporary scaffolds restore natural vasomotion and vessel geometry over 2-3 years, eliminating permanent metallic cages in coronary arteries and revolutionizing young patient PCI treatments.
Interventional cardiologists in Kathmandu encounter complex clinical cases daily. Our Drug-Eluting Stents and peripheral access systems are specifically engineered to perform under demanding catheterization procedures:
High strut flexibility and wide side-branch access capability allow cardiologists at Shahid Gangalal National Heart Center to execute provisional side-branch stenting or Culotte techniques with seamless balloon passage and minimal strut distortion.
Our Cobalt-Chromium alloy matrix provides high pushability and crossability, enabling navigation through severe vessel calcification common in elderly patients across Bagmati Province without risk of drug coating delamination.
Rapid deployment mechanisms and exceptional balloon inflation response speed up door-to-balloon times during emergency PCI procedures in Kathmandu's leading intensive cardiac care units.
Uniform Sirolimus dosing ensures effective suppression of smooth muscle cell proliferation in small diameter vessels (2.25mm - 2.50mm), significantly cutting repeat revascularization (TLR) rates.
SJ Medical is committed to providing end-to-end professional support for medical equipment importers and hospital networks in Kathmandu. From initial pre-sales engineering consultations to customized branding, OEM private labeling, and localized packaging compliant with Nepalese law, we deliver unmatched flexibility.
Explore Our Certified Vascular Devices and Hospital Care Systems Available for Direct Import to Kathmandu
Precision Guidewires, Sheath Introducers, and Peripheral Diagnostic Kits
Expert Guidance on Importing, Regulatory Compliance, and Technical Specifications of Drug-Eluting Stents
Our stent platforms primarily utilize Sirolimus (Rapamycin) or Everolimus, micro-encapsulated in bioresorbable or polymer-free formulations. These limus-family drugs are proven to inhibit mammalian target of rapamycin (mTOR), suppressing smooth muscle cell proliferation while maintaining low inflammatory responses in coronary arteries.
Hangzhou SJ Medical provides a complete regulatory dossier to our authorized distributors in Kathmandu. This includes ISO 13485 certificates, CE Full Quality Assurance Certificates, Free Sale Certificates (FSC), sterile barrier validation reports, and comprehensive clinical trial evaluation data required for rapid DDA approval.
Our Drug-Eluting Stent systems have a validated shelf-life of 24 to 36 months when stored in their original unopened EO-sterilized blister packaging under controlled conditions (15°C to 25°C). We utilize temperature monitoring data loggers during air freight to guarantee product integrity upon arrival at Tribhuvan International Airport.
For standard SJ Medical branded devices, we accommodate flexible order quantities tailored for tender pilots or hospital stocking in Nepal. For customized OEM/ODM projects (such as custom balloon catheter lengths or specialized packaging), our MOQs typically start at 100 units per size matrix.
Thin-strut stents (<80 μm) exert less shear stress disruption on intra-coronary blood flow, promoting faster re-endothelialization. This significantly lowers thrombosis risk, enabling interventionalists in Kathmandu to shorten Dual Antiplatelet Therapy (DAPT) duration when clinically appropriate.
We offer competitive commercial terms including Telegraphic Transfer (T/T), Letter of Credit (L/C at sight), and FOB/CIF arrangements. Shipments to Kathmandu are routinely handled via express air freight (DHL, FedEx, or air cargo charters) to guarantee rapid delivery within 3 to 5 business days.
Get direct factory pricing, technical specifications, and regulatory registration support for high-performance Drug-Eluting Stents and interventional catheter devices.
Send Inquiry Now
